Financhill
Sell
26

ACXP Quote, Financials, Valuation and Earnings

Last price:
$3.45
Seasonality move :
-17.78%
Day range:
$3.45 - $3.53
52-week range:
$3.17 - $25.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.46x
Volume:
40K
Avg. volume:
69.4K
1-year change:
-80.23%
Market cap:
$5.3M
Revenue:
--
EPS (TTM):
-$6.49

Earnings Data

Next earnings date for ACXP
Mar 17
2026
Most recent earnings per share
-$1.23
Beat by $0.26
(Nov 12/2025)
Consensus Estimate
-$1.49
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ACXP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/17/2026 Q4 -- -- -- -$1.00 --
11/12/2025 Q3 -- -- -$1.23 -$1.49 $0.26
08/12/2025 Q2 -- -- -$1.89 -$2.10 $0.21
05/15/2025 Q1 -- -- -$0.11 -$2.80 $2.69
03/18/2025 Q4 -- -- -$3.27 -$3.60 $0.33
11/13/2024 Q3 -- -- -$0.17 -$4.60 $4.43
08/09/2024 Q2 -- -- -$0.26 -$5.60 $5.34
05/15/2024 Q1 -- -- -$0.28 -$4.80 $4.52
03/18/2024 Q4 -- -- -$0.38 -$5.20 $4.82
11/14/2023 Q3 -- -- -$0.24 -- --
08/14/2023 Q2 -- -- -$0.28 -- --
05/12/2023 Q1 -- -- -$0.25 -- --
03/16/2023 Q4 -- -- -$0.28 -- --
11/14/2022 Q3 -- -- -$0.32 -- --
08/16/2022 Q2 -- -- -$0.26 -- --
05/11/2022 Q1 -- -- -$0.26 -- --
03/17/2022 Q4 -- -- -$0.26 -- --
11/15/2021 Q3 -- -- -$0.46 -- --
08/17/2021 Q2 -- -- -$0.40 -- --
03/31/2021 Q1 -- -- -$0.15 -- --
12/31/2020 Q4 -- -- -$2.29 -- --
09/30/2020 Q3 -- -- -$2.76 -- --
06/30/2020 Q2 -- -- -$0.09 -- --
03/31/2020 Q1 -- -- -$0.13 -- --

Acurx Pharmaceuticals, Inc. Earnings Questions

  • How Much did Acurx Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Acurx Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Acurx Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Acurx Pharmaceuticals, Inc. announced earnings per share of -$1.23 which represents a beat of analyst forecast a -$1.49 per share.

  • Is Acurx Pharmaceuticals, Inc. Profitable?

    Acurx Pharmaceuticals, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Acurx Pharmaceuticals, Inc. EPS Next Year?

    Acurx Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$17.45 per share to -$17.80 per share next year representing a decrease of -67.28%.

  • When is Acurx Pharmaceuticals, Inc.'s Earnings Date?

    Acurx Pharmaceuticals, Inc.'s next earnings date is March 17, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock